Dr. Jacqueline Goldminz, MD
Dermatology
9+
Years in Practice
Practice Locations
1 location
About Dr. Jacqueline Goldminz
Jacqueline Goldminz, MD is a healthcare provider.
Specialty Definition
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
5
Years Experience
1
Location
1
States Licensed
Credentials & Board Certifications
Additional Specialties
Primary Specialty
DermatologyCredentials verified via NPI Registry (NPPES)
Education & Training
Medical School
Boston University School Of Medicine
Class of 2021
Licenses & Practice States
Licensed in 1 state
| State | License | Classification | Primary |
|---|---|---|---|
| Massachusetts | 286388 | Dermatology | |
| Massachusetts | 271368 | Internal Medicine | — |
Public Data Summary for Dr. Jacqueline Goldminz
In their first decade of practice, Dr. Jacqueline Goldminz represents the newer generation of dermatology providers, MD, after earning their medical degree at Boston University School Of Medicine in 2021. Dr. currently practices at in Auburndale, Massachusetts. Their National Provider Identifier (NPI) is 1215466719, and the profile below combines data from CMS NPPES, Medicare billing records, the HHS OIG exclusion list, and — where available — CMS Open Payments, Medicare Utilization, and Part D prescriber summaries.
CMS Medicare data shows Dr. Jacqueline Goldminz as a lower-volume dermatology provider, treating approximately 158 Medicare beneficiaries and delivering 637 services in the most recent reporting year. That panel size indicates a smaller, more selective practice pattern.
Under the Physician Payments Sunshine Act, CMS reports that Dr. Jacqueline Goldminz received $143 in industry payments in 2023. Payments at this scale are typical for most practicing physicians and generally reflect routine educational activities.
Transparency & Safety
Public records from CMS and OIG databases
Industry Payments
$143
Total payments received from pharmaceutical and medical device companies in 2023.
Source: CMS Open Payments (Sunshine Act)
Opioid Prescribing
This provider has no opioid prescriptions on file in Medicare Part D data.
Insurance & Accessibility
Reviews
Community reviews for Dr. Jacqueline Goldminz
--
0 reviews
Dermatology Providers Nearby
Same primary specialty near ZIP 02481
FAQ
Frequently asked questions about Dr. Jacqueline Goldminz
What does Dr. Jacqueline Goldminz specialize in?
Dr. Jacqueline Goldminz specializes in Dermatology. Secondary taxonomy filings also list Internal Medicine.
Where does Dr. Jacqueline Goldminz practice?
Dr. Jacqueline Goldminz practices at in Auburndale, Massachusetts.
Does Dr. Jacqueline Goldminz accept Medicare?
CMS records show that Dr. Jacqueline Goldminz accepts Medicare assignment. CMS billing data shows 158 Medicare beneficiaries treated in the most recent reporting year.
What is Dr. Jacqueline Goldminz's NPI number?
Dr. Jacqueline Goldminz's National Provider Identifier (NPI) is 1215466719. This is the unique 10-digit number the Centers for Medicare & Medicaid Services assigns to every practicing US healthcare provider. You can verify this number directly at the NPPES NPI Registry.
How long has Dr. Jacqueline Goldminz been practicing?
Dr. Jacqueline Goldminz has approximately 9 years of practice experience, having graduated from Boston University School Of Medicine in 2021.